Astellas Pharma Inc. Site Map
 
Home > Therapeutic Areas > Products > U.S. Marketed Products
   
U.S. Marketed Products

Following is a list of Astellas' products marketed in the U.S. This information is intended for U.S. residents only.

Cardiology

Adenoscan® (adenosine injection)

Lexiscan® (regadenoson)

Vaprisol® (conivaptan)

Dermatology

Protopic® (tacrolimus) Ointment

Immunology

Prograf® (tacrolimus)

Infectious Disease

AmBisome® (amphotericin B) liposome for injection

MYCAMINE® (micafungin sodium) for injection

Oncology

TARCEVA® (erlotinib) tablets

XTANDI® (enzalutamide)

Urology

Myrbetriq™ (mirabegron)

VESIcare® (solifenacin succinate)

All trademarks are Astellas’ except:
AmBisome is a registered trademark of Gilead Sciences, Inc.
Tarceva is a registered trademark of OSI Pharmaceuticals, LLC.

   
 
Copyright © 2005 - 2013 Astellas Pharma US, Inc. Site Map  Privacy Policy   Legal Disclaimer  Contact Us